Mario A. Anzano
Impact in
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
- Rehabilitation top 1%
- Wound Healing and Treatments
Papers in
-
- TGF-β signaling in diseases 8
- Retinoids in leukemia and cellular processes 6
- Viral Infectious Diseases and Gene Expression in Insects 6
- Oncology 14
- Cancer Cells and Metastasis 3
- Co-authors
- Anita B. Roberts (19 shared papers)Michael B. Sporn (18 shared papers)Joseph M. Smith (15 shared papers)Lois C. Lamb (5 shared papers)N S Roche (3 shared papers)Lalage M. Wakefield (3 shared papers)David F. Stern (1 shared paper)Chu‐Xia Deng (3 shared papers)
- Journals
- American Journal Of Pathology (3 papers)International Journal of Cancer (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Nutrition (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- United StatesThailandSouth Korea
In The Last Decade
Mario A. Anzano
41 papers receiving 5.6k citations
Mario A. Anzano's Hit Papers
Peers
Comparison fields: 5 of 119
- Immunology and Allergy 400
- Rehabilitation 407
- Molecular Biology 3.8k
- Oncology 1.5k
- Cancer Research 758
Countries citing papers authored by Mario A. Anzano
This map shows the geographic impact of Mario A. Anzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario A. Anzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario A. Anzano more than expected).
Fields of papers citing papers by Mario A. Anzano
This network shows the impact of papers produced by Mario A. Anzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario A. Anzano. The network helps show where Mario A. Anzano may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario A. Anzano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Type beta transforming growth factor: a bifunctional regulator of cellular growth. Hit paper breakdown → | 1985 | 972 |
| 2 | New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Hit paper breakdown → | 1981 | 762 |
| 3 | Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response Hit paper breakdown → | 1999 | 757 |
| 4 | 1983 | 305 | |
| 5 | 1983 | 303 | |
| 6 | 2002 | 245 | |
| 7 | 2004 | 238 | |
| 8 | Transforming growth factors from neoplastic and nonneoplastic tissues. | 1983 | 228 |
| 9 | Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. | 1982 | 224 |
| 10 | 1982 | 171 | |
| 11 | Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. | 1994 | 168 |
| 12 | 1988 | 156 | |
| 13 | 2003 | 142 | |
| 14 | 1996 | 134 | |
| 15 | 1985 | 116 | |
| 16 | 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. | 1994 | 106 |
| 17 | Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. | 1994 | 97 |
| 18 | Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. | 1995 | 85 |
| 19 | 1986 | 82 | |
| 20 | Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. | 1993 | 69 |
About Mario A. Anzano
Mario A. Anzano is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 6.0k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (8 papers), Retinoids in leukemia and cellular processes (6 papers), Estrogen and related hormone effects (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Virus-based gene therapy research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Mesenchymal stem cell research (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Immunology and Allergy (400 citations), Rehabilitation (407 citations), Molecular Biology (3.8k citations), Oncology (1.5k citations) and Cancer Research (758 citations). Mario A. Anzano has collaborated with scholars based in United States, Thailand and South Korea. Frequent co-authors include Anita B. Roberts, Michael B. Sporn, Joseph M. Smith, Lois C. Lamb, N S Roche, Lalage M. Wakefield, David F. Stern, Chu‐Xia Deng, John J. Letterio and Charles A. Frolik. Their work appears in journals such as American Journal Of Pathology, International Journal of Cancer, Proceedings of the National Academy of Sciences, Journal of Nutrition and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.